导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.48% | 535/1050 |
| 近一周 | -1.89% | 356/1104 |
| 近一月 | -2.76% | 308/1102 |
| 近一季 | -11.52% | 737/1092 |
| 近半年 | -5.13% | 613/1070 |
| 近一年 | 2.81% | 517/1018 |
| 近两年 | 75.80% | 321/926 |
| 近三年 | 42.19% | 310/834 |
| 成立以来 | 170.16% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.70% 433/1070 |
16.89% 428/1101 |
- - |
- - |
| 2025 | 37.73% 355/1065 |
8.30% 211/1014 |
5.34% 279/1038 |
21.12% 575/1050 |
-0.32% 474/1065 |
| 2024 | 7.15% 354/1011 |
-3.73% 520/960 |
-1.49% 404/983 |
8.12% 768/991 |
4.49% 152/1011 |
| 2023 | -3.08% 162/952 |
6.00% 254/880 |
3.92% 57/895 |
-7.34% 457/915 |
-5.05% 508/952 |
| 2022 | -20.60% 347/867 |
-6.78% 51/773 |
6.75% 423/806 |
-11.00% 302/845 |
-10.35% 792/867 |
| 2021 | 30.88% 67/740 |
4.32% 57/580 |
10.66% 337/659 |
13.93% 38/704 |
-0.49% 458/740 |
| 2020 | 47.06% 255/554 |
5.65% 66/419 |
27.39% 155/466 |
10.75% 234/517 |
-1.34% 496/554 |
| 2019 | 34.07% 266/410 |
28.39% 469/1149 |
-9.46% 1006/1231 |
5.97% 183/390 |
8.83% 203/410 |
| 2018 | -31.31% 236/349 |
- - |
- - |
- - |
-12.43% 645/1080 |
| 2017 | -14.22% 203/285 |
- - |
- - |
- - |
- - |
| 2016 | 3.73% 21/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 长信量化中小盘股票 VS. 东吴新产业精选股票A(580008) |